Astra Zeneca has released a new drug with antibodies against K-19
The experimental drug cocktail with antibodies of the company “AstraZeneca” manages to reduce severe illness or death in non-hospitalized patients with COVID-19, show results in a study at a late stage, said the British drug manufacturer, quoted by WORK. The drug, called AZD7442, reduced the risk of developing severe COVID-19 or death by 50% in … Read more